Abstract
Recurrent urolithiasis are a significant cause of morbidity and discomfort. Not only are they painful, but they also result in repeated expensive and sometimes invasive medical interventions. In some patients, a treatable cause is diagnosed, which can result in a significant reduction in clinically significant urolithiasis. However, in roughly 15–20% of calcium oxalate stone formers, no specific cause can be identified [1, 2]. Given that kidney stones affect 0.5–1% of the population per year in the United states and that up to 80% of these are calcium oxalate stones, idiopathic stone formers comprise a significant portion of the population [3, 4]. Formulating a treatment plan for these patients, in whom no correctable cause is identified, presents a unique challenge.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005;115(10):2598–608.
Kumar B, Abbas AK, Fausto N, Aster JC. Urolithiasis. In: Schmitt W, Guruliow R, editors. Robbins and Cotran pathologic basis of disease. 8th ed. Philadelphia: Saunders Elsevier; 2004. p. 962–3.
Pearle MS, Roehrborn CG, Pak CYC. Meta-analysis of randomized clinical trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol. 1999;13(9):679–85.
Pak CYC. Kidney stones. Lancet. 1998;351(9118):1797–801.
Penniston KL. The nutrition consult for recurrent stone formers. Curr Urol Rep. 2015;16(7):47.
Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Manoj M, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014;192(2):316–24.
Penniston KL, Nakada SY. Diet and alternative therapies in the management of stone disease. Urol Clin N Am. 2013;40:31–46.
Robertson WG. Dietary recommendations and treatment of patients with recurrent idiopathic calcium stone disease. Urolithiasis. 2016;44:9–26.
Stuart RO, Hill K, Poindexter J, Pak CYC. Seasonal variations in urinary risk factors among patients with nephrolithiasis. J Lithotr Stone Dis. 1991;3(1):18–27.
Nouvenne A, Meschi T, Guerra A, Allegri F, Prati B, Borghi L. Dietary treatment of nephrolithiasis. Clin Cases Miner Bone Metab. 2008;5(2):135–41.
Rodgers AL. Effect of mineral water containing calcium and magnesium on calcium oxalate urolithiasis risk factors. Urol Int. 1997;58(2):93–9.
Schwartz BF, Schenkman NS, Bruce JE, Leslie SW, Stoller ML. Calcium nephrolithiasis: effect of water hardness on urinary electrolytes. Urology. 2002;60(1):23–7.
Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med. 1998;128(7):534–40.
Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Soda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol. 2013;8(8):1389–95.
Parks JH, Worcester EM, O’Connor RC, Coe FL. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int. 2003;63(1):255–65.
Ruml LA, Pearle MS, Pak CYC. Medical therapy – calcium oxalate urolithiasis. Urol Clin N Am. 1997;24(1):117–33.
Heller HJ, Doerner MF, Brinkley LJ, Adams-Huet B, Pak CY. Effect of dietary calcium on stone forming propensity. J Urol. 2003;169(2):470–4.
Pak CY, Odvina CV, Pearle MS, Sakhaee K, Peterson RD, Poindexter JR, et al. Effect of dietary modification on urinary stone risk factors. Kidney Int. 2005;68(5):2264–73.
Siener R, Jahnen A, Hesse A. Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystalization. Eur J Clin Nutr. 2004;58:270–6.
Hess B, Jost C, Zipperle L, Takkinen R, Jaeger P. High-calcium intake abolishes hyperoxlauria and reduces urinary crystalization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant. 1998;13:2241–7.
Simpson DP. Regulation of renal citrate metabolism by bicarbonate ion and pH: observations in tissue slices and mitochondria. J Clin Invest. 1967;46(2):225–38.
Meschi T, Maggiore U, Fiaccadori E, Schianchi T, Bosi S, Adorni G, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004;66(6):2402–10.
Shuster J, Jenkins A, Logan C, et al. Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol. 1992;45:911–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Doersch, K., Lowry, P. (2018). Therapeutic Nutritional Strategies When No Risk Factors Are Apparent. In: Lowry, P., Penniston, K. (eds) Nutrition Therapy for Urolithiasis. Springer, Cham. https://doi.org/10.1007/978-3-319-16414-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-16414-4_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16413-7
Online ISBN: 978-3-319-16414-4
eBook Packages: MedicineMedicine (R0)